Changing concepts in the management of differentiated thyroid cancer.

Authors

• Charles M Intenzo
• Serge Jabbour
• Hung Q Dam
• David M Capuzzi

Publication/Presentation Date

10-1-2005

Abstract

The management of patients with differentiated thyroid cancer has changed significantly over the last few decades. Mortality has decreased as the result of earlier detection, refined surgical approaches, subsequent radioiodine ablation, and the development of more sensitive methods for detecting and monitoring disease recurrence. The latter has been facilitated by serum thyroglobulin measurements, the use of recombinant human thyrotropin, and the use of 18F-deoxyglucose/positron emission tomography in selected instances where radioiodine imaging fails to locate known or suspected recurrent or metastatic disease.

Volume

35

Issue

4

First Page

257

Last Page

265

ISSN

0001-2998

Published In/Presented At

Intenzo, C. M., Jabbour, S., Dam, H. Q., & Capuzzi, D. M. (2005). Changing concepts in the management of differentiated thyroid cancer. Seminars in nuclear medicine, 35(4), 257–265. https://doi.org/10.1053/j.semnuclmed.2005.05.003

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

16150246

Department(s)

Administration and Leadership

Document Type

Article